Page last updated: 2024-09-03

benzyloxycarbonyl-phe-ala-fluormethylketone and isatin beta-thiosemicarbazone

benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with isatin beta-thiosemicarbazone in 1 studies

Compound Research Comparison

Studies
(benzyloxycarbonyl-phe-ala-fluormethylketone)
Trials
(benzyloxycarbonyl-phe-ala-fluormethylketone)
Recent Studies (post-2010)
(benzyloxycarbonyl-phe-ala-fluormethylketone)
Studies
(isatin beta-thiosemicarbazone)
Trials
(isatin beta-thiosemicarbazone)
Recent Studies (post-2010) (isatin beta-thiosemicarbazone)
5054508

Protein Interaction Comparison

ProteinTaxonomybenzyloxycarbonyl-phe-ala-fluormethylketone (IC50)isatin beta-thiosemicarbazone (IC50)
CruzipainTrypanosoma cruzi5.75

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelo, IC; Conti, P; De Micheli, C; Ettari, R; Micale, N; Pinto, A; Tamborini, L1

Other Studies

1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and isatin beta-thiosemicarbazone

ArticleYear
Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
    Journal of medicinal chemistry, 2013, Jul-25, Volume: 56, Issue:14

    Topics: Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosomiasis, African

2013